SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CIMA who wrote (629)10/26/1997 12:18:00 AM
From: Mark Bartlett  Read Replies (1) of 14101
 
CIMA,

<<Mark, you seem to be on top of DMX. It's been quiet lately. What's next on the horizon to move the stock? What are you looking to get out of the stock?>>

This one is a long-term hold - barring no unforseen negative news. Basically there are two things that could move the stock in the next few weeks\months ahead. The first is the approval of Pennsaid in Canada or possibly the UK. IMO this will move the stock to the 6-7 dollar range. The second is the green light for the phase 3 studies of WF10 and/or the publication of a positive review of WF10 in a peer reviewed science journal (Science\Nature).

If we happen to get lucky and get the approval of Pennsaid AND the green light\Science publication in the weeks\months ahead, I think 10 bucks is not out of the question. A high percentage of drugs that make it to phase 3 eventually _do get approved. In addition, we are awaiting the final nod for the WF10 phase 2 cancer studies.

Because Pennsaid has been so extensively tested in Canada, I am 95% confident that it will get approval. Our government is not known to be the quickest to approve drugs - but that has positive aspects too i.e., things have been thoroughly checked.

MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext